Publications in collaboration with researchers from Universidad Nacional Autónoma de México (2)

2023

  1. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

2022

  1. New diagnosis of mother-to-child transmission of HIV in 8 Latin-American countries during 2018

    BMC Infectious Diseases, Vol. 22, Núm. 1